Clinicians are reminded to include non-prescription supplement history when evaluating thrombotic events in younger adults ...

Creatine monohydrate is widely used in sports for boosting energy stores during high-intensity activity and enhancing ...

Andy Davis, SVP of Cardiovascular & Head of Metabolic Franchise, reported early REDEMPLO launch performance: "Over 100 ...

"It was incredibly frightening. I had never felt so close to something life-threatening before," Nikki Bahan, a mom of three, ...

Learn more about whether Alnylam Pharmaceuticals, Inc. or Arrowhead Pharmaceuticals, Inc. is a better investment based on ...

On January 12, 2026, the European Commission for the Environment, Climate Change, and Energy (the European Commission) ...

On Wednesday, January 20, 2026, a three-judge panel of the United States Court of Appeals for the District of Columbia ...

A PFAS-remediation project using sustainably manufactured granulated activated carbon for drinking water demonstrates how ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its fiscal 2026 first quarter ended December 31, 2025. The Company is hosting a conference call today, February 5, ...

Vitamin D deficiency can lead to bone softening and subsequent bone pain and fractures. Learn its causes, diagnosis, treatment, and prevention.

Learn more about whether Arrowhead Pharmaceuticals, Inc. or Gilead Sciences, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

@hopkinskimmel researchers develop novel liquid biopsy approach to identifying early-stage cancers. › ...